Integral Diagnostics Ltd. (AU:IDX) has released an update.
Integral Diagnostics Ltd. reported a stronger second half for FY24, highlighting its focus on delivering high-acuity diagnostic services across Australia and New Zealand. The company operates 90 clinics, employing a team of highly skilled radiologists, and continues to expand its PET-CT facilities. Regulatory changes in Australia, including de-regulation of MRI services and Medicare updates, present opportunities for growth in the diagnostic imaging sector.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
